Celera Posts 21 Percent Q3 Revenue Decline, Will Cut 50 Jobs

The firm's lab services revenues were hurt by lower sample volume, but were partially offset by a higher average price per sample. Celera also announced a restructuring program intended to cut costs by $10 million next year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.